Cardiac Sarcoidosis Randomized Trial

Cardiac Sarcoidosis Randomized Trial

Prospective randomized controlled trial comparing low dose Prednisone/Methotrexate combination to standard dose Prednisone in patients diagnosed with acute active clinically manifest cardiac sarcoidosis and not yet treated. The Investigators hypothesize that low dose Prednisone/Methotrexate combination will be as effective as standard dose Prednisone, and result in significantly better quality of life and less toxicity than standard dose Prednisone.

Pharmaceutical medication involved
Recruiting patients only

Drug - Prednisone

Oral prednisone tablet

Drug - Methotrexate

Oral, subcutaneous, or intramuscular methotrexate

Cardiac Sarcoidosis Multi-Center Randomized Controlled Trial